Steward Partners Investment Advisory, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$1,041
-93.8%
5,200
-36.6%
0.00%
Q2 2023$16,892
-37.6%
8,2000.0%0.00%
Q1 2023$27,060
+101.2%
8,2000.0%0.00%
Q4 2022$13,448
-62.6%
8,2000.0%0.00%
-100.0%
Q3 2022$36,000
+100.0%
8,200
+22.4%
0.00%
Q2 2022$18,000
-30.8%
6,700
-13.0%
0.00%
Q1 2022$26,000
-33.3%
7,700
-20.6%
0.00%
-100.0%
Q4 2021$39,000
-30.4%
9,700
-42.9%
0.00%0.0%
Q3 2021$56,000
-22.2%
17,000
-10.5%
0.00%0.0%
Q2 2021$72,000
-100.0%
19,000
-69.2%
0.00%
-50.0%
Q1 2021$235,928,000
+341824.6%
61,600
+302.6%
0.00%
+100.0%
Q4 2020$69,000
-84.0%
15,300
-39.8%
0.00%
-90.9%
Q3 2020$430,000
+54.7%
25,400
+2.4%
0.01%
+37.5%
Q2 2020$278,000
+212.4%
24,800
+28.5%
0.01%
+166.7%
Q1 2020$89,000
+535.7%
19,300
+451.4%
0.00%
Q4 2019$14,000
+55.6%
3,500
+40.0%
0.00%
Q3 2019$9,0000.0%2,5000.0%0.00%
Q2 2019$9,000
-60.9%
2,500
-58.3%
0.00%
-100.0%
Q3 2018$23,000
+155.6%
6,000
+100.0%
0.00%0.0%
Q1 2018$9,000
-18.2%
3,0000.0%0.00%0.0%
Q4 2017$11,0003,0000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Weaver Consulting Group 130,000$437,0000.21%
Ikarian Capital, LLC 304,161$1,022,0000.13%
ABNER HERRMAN & BROCK LLC 265,000$890,0000.12%
S.C. Financial Services, Inc. 15,285$51,0000.06%
JMAC ENTERPRISES LLC 45,430$153,0000.04%
CFO4Life Group, LLC 12,000$40,0000.01%
OSAIC HOLDINGS, INC. 10,839$1,329,0000.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 29,186$98,0000.00%
RAYMOND JAMES & ASSOCIATES 190,403$640,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders